Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your math is way off. They would require 62.5 million to buy the 250 mm shares at .25 cents.
Clearly has no clue what he's talking about folks.
Looks like you need more shovels Ex.
I do believe the company is speaking through this lack of communication. In the next 2 weeks I believe we will know firmly what the company has been working on in the background. I believe there is some very good news coming and the silence from the company speaks volumes to me.
Lmao!!!!!
Lolling. We've been laughing about that in our little group for weeks thermo.
Anyone see Hygro?
Hygro,
I appreciate your post. Thank you.
I ran into someone who knows you in real life. He told me to say hi! To you.
Appreciate your continued misinformation. Cheers!
Some people can't handle the truth bio. Well said.
Second this. Great, concise explanation on the difference between DCVax and Optune trials.
Agree with you Hoff 110%.
Clearly keep repeating the same bs lmao. The optune trial had over 50% with IDH1 mutation whereas DCVax had only 7 of 331. Completely skewed results in the optune trial.
dcvax will be the new standard of care. Optune will be put in the garbage where it belongs.
Sharing a 5 stack of munchkins right now with my dog :)
Guaranteed untrue. You'll be exposed soon ;)
Sure sure. We know what team you play for, and it's not the team that's rooting for the company to succeed.
Don't worry.. I know who you are ;)
PM let's be real. You don't own any shares whatsoever.
Keith Knutson has been following DCVax for a very long time. He wrote a technology evaluation paper in 2002: https://mayoclinic.pure.elsevier.com/en/publications/technology-evaluation-dcvax-northwest-biotherapeutics/fingerprints/
He is definitely talking about Northwest Bio & DCVax
Agree with this Senti.
I too also was the CEO of Merck for 110 years, but just retired this past April.
If anyone wants to know why NWBO is one of the most targeted and maliciously manipulated companies around, they need not to look any further than this statement here:
"Northwest Biotherapeutics is a biotechnology company focused on developing personalized immunotherapy products designed to treat cancers more effectively than current treatments, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both North America and Europe."
This in of itself explains the well funded ongoing clownshow we are witnessing before our eyes. I can't imagine all of the money behind wanting to see this treatment fail.
Lmao. I also was the president of the United States.
AACR journal has updated their page that more accurately reflects the trial information: https://aacrjournals.org/cdnews
I do think that the valuation will come down to the companies abilities to scale and sell the product. If we learn that Flaskworks is approved and the company has the capability to manufacture/utilize automated processing at scale, and the demand is there - which we know it is. The valuations will be determined by the addressable market that is able to utilize DCVax, which I do not believe 20-50 billion dollars is unrealistically by any means.
Thanks man. Doing a lot better. Was weird to get it finally after being exposed probably 40x these past 2.5 years.
I just got through the BA5 variant. I'm still going through the remaining cough. It knocked me out for a good bit. I avoided covid for 2.5 years but finally got hit by this one.
6/24/22
Noticed that too. Good call out. Should be very interesting. What a pleasant surprise seeing this come together.
I believee @ATL is counting the overall gross cost as nwbo revenue, which I believe is accurate. The subsequent distribution will be considered costs.
Hah - the format of this discussion board drives me absolutely nuts.
Clueless posting as usual. Thanks Jerry
I don't think a conclusion can be drawn in either direction. Marnix said that they do not comment on any interactions with the regulatory bodies.
Thanks lykiri as always.
You are incorrect. Adam has explicitly posted, criticized and acknowledged that NWBO has changed the endpoints, initially many years ago and several times since then.
He chose to misuse data from clinical trials.gov, when there were 3 other clinical trial registrar websites with the correct information.
Further, this was clearly discussed in the presentation that PFS was not an endpoint. He chose to state otherwise because it supports his false narrative.
You are wrong in trying to say this is a false accusation of AF. Your marble analogy does not make sense here.
Agreed.
The explanation is that they cannot speak on the results until journal embargo is lifted. If journal comes and the company doesn't address, then I believe it to be a fair and warranted judgment. Until then I'm holding patiently until the companies plan plays out.
It is clearly threatening and not something you do as a professional. I am not saying that there is a legal case here, but it is very clear and obvious to those that have the ability to think logically, that is an act of intimidation and threat. The behavior of a true narcissistic pos. He will get what's coming.
The act in of itself is threatening regardless of what was said. The act of seeking someone out, leaving them a voicemail and asking them to hear their voice is an act of intimidation and threat.